HIF1α et HIF2α sont des protéines largement impliquées dans le développement de pathologies posant des problèmes majeurs de santé publique, comme le cancer. Leur activité, qui est régulée prioritairement par leur stabilité via le système ubiquitine-protéasome, coordonne de nombreux processus cellulaires susceptibles de favoriser le développement de ces maladies. Un enjeu récent de la recherche thérapeutique est d’identifier des partenaires protéiques pouvant réguler les protéines HIFα, afin de mettre au point des thérapies ciblées. Les protéines de choc thermique (HSPs) sont une classe de protéines dont une des fonctions essentielles est de réguler l’homéostasie protéique dans la cellule, en interagissant avec le protéasome. Certaines d’entre elles, HSP27 et HSP90, ont la faculté de pouvoir réguler spécifiquement la stabilité de nombreuses protéines souvent elles-mêmes impliquées dans l’apparition de ces pathologies. L’objectif de ce travail était de savoir si ces deux HSPs peuvent contrôler la stabilité de la protéine HIF2α. Nos résultats suggèrent qu’HSP27 pourrait stimuler la dégradation de HIF2α en favorisant son ubiquitination. Ce résultat est surprenant, en raison du rôle connu d’HSP27 dans la progression tumorale. Il est donc nécessaire de le confirmer et d’en préciser les processus biologiques sous-jacents. D’autre part, nos autres résultats semblent confirmer qu’HIF2α est une protéine cliente d’HSP90. De plus, nous montrons pour la première fois que l’inhibition d’HSP90 par le 17-DMAG diminue la production de VEGF dépendante de HIF2α. Des travaux récents suggèrent qu’HIF2α a un rôle prédominant dans la progression tumorale, et peut constituer une cible globale de choix dans plusieurs types de cancer. Il conviendrait d’évaluer la capacité des inhibiteurs d’HSP90 à supprimer des fonctions de HIF2α nouvellement décrites, comme son rôle dans la maintenance des cellules souches cancéreuses. / Both HIF1α and HIF2α proteins are highly involved in the development of pathologies, such as cancers, which are prime public health issues. These proteins are primarily controlled at the protein level by ubiquitin-dependant degradation, and regulate numerous cellular processes which are likely to favor the development of these diseases. A recent issue in therapeutic research is to identify partners that might regulate the expression and the activity of the HIFα proteins, with the aim to elaborate targeted therapies. Heat shock proteins (HSPs) form a family of proteins whose main function is to regulate protein homeostasis in cells, which they achieve through interaction with the ubiquitin-proteasome pathway. HSP27 and HSP90 are able to specifically control the stability of certain client proteins involved in those pathologies. In the present work, we sought to determine whether these HSPs could regulate the expression of the HIF2α protein. Our results suggest that HSP27 may induce ubiquitin and proteasome-dependant degradation of HIF2α, which is quite intriguing given the well-known role of HSP27 in tumor promotion. This needs to be confirmed and the underlying biological significance of such a regulation remains to be defined. Our results also may confirm that HIF2α is an HSP90 client protein. Moreover, we show for the first time that inhibition of HSP90 by 17-DMAG decreases the HIF2α-dependant VEGF production. Recent studies emphasize HIF2α as a major promoter of tumor progression, and suggest that HIF2α may constitute an attractive global target in several cancer types. Therefore, the ability of HSP90 inhibitors to disrupt newly described HIF2α functions, such as cancer stem cell maintenance, should be evaluated.

The intracellular sperm injection (ICSI) technique is a very effective tool for the fertilization research. In the newly established laboratory at the Faculty of Science of the Charles University it was necessary to introduce this method and define the early developmental potential of fertilized oocytes. After fertilization oocytes were incubated to the blastocyst stage with a success comparable with other laboratories (17%). The ubiquitin-proteasome system which plays a major role in a protein degradation within cells is involved in a regulatory mechanism of sperm maturation. It is also responsible for a penetration of a vitelline membrane. In these processes ubiquitin residues are localized extracellulary. High level of sperm ubiquitination correlates with their low quality. Hypotetically it can be expected that the ubiqutination of impaired sperm cells can be used as a negative marker for their recognition and degradation by 26S proteasome complex localized. Experiments in this diploma thesis were designed based on the hypothesis that the executive part of the selective mechanism is the 26S proteasome. Therefore the effect of MG132 peptide inhibition of the 20S proteasome on the pronuclei formation and subsequent early embryonic development after ICSI was studied. Inhibition of 20S proteasome...

<p>  G Protein Coupled Receptor (GPCR) signaling plays a key role in intercellular communication and regulates many physiological processes relevant to disease. Approximately 30-40% of all FDA approved drugs target GPCR pathways, but limitations and off-target side effects remain obstacles. Regulator of G protein Signaling (RGS) proteins negatively modulate GPCR signaling by accelerating deactivation of the Gα subunit and thus represent a novel alternative to current approaches. While research on RGS proteins and how they are regulated has expanded rapidly, there are still gaps in knowledge for some members of the RGS family. One example is RGS2, which is selective for Gαq signaling. Lowered RGS2 levels are implicated in numerous diseases, and while the E3 ligase responsible for facilitating degradation of RGS2 has been identified more work needs to be done to viably drug it to enhance RGS2 protein levels. In this thesis, I explore how FBXO44, an E3 ligase substrate recognition component responsible for RGS2 degradation, interacts with RGS2 to explore approaches to inhibit degradation.</p> <p><br></p> <p>While the FBXO44-RGS2 interaction has been demonstrated previously, the degron sequence of RGS2 remained unknown. We hypothesized that FBXO44 binds RGS2 at its Nterminus and investigated this using N-terminally truncated RGS2 constructs. Our results indicated that FBXO44 binds between residues 5 and 16 of RGS2, as removal of these stabilized RGS2 against proteasomal degradation. Based on these results we designed a peptide microarray to identify important residues and properties for FBXO44 in vitro and found that Cys13 is essential for FBXO44 binding.</p> <p><br></p> <p>We also developed and optimized a high-throughput split luciferase screen to identify potential inhibitors of the FBXO44-RGS2 interaction. After forming a cell-line stably expressing tagged FBXO44 and RGS2 and optimizing assay condition, we achieved a robust assay for screening as determined by Z’-factor. <br>  </p>

No description available.

Das 20S Proteasom ist das Kernelement des Ubiquitin-Proteasom-Systems und baut fehlerhafte, nicht mehr benötigte und oxidierte Proteine ab, wobei drei katalytisch aktive Untereinheiten die Polypeptidkette schneiden. Das proinflammatorische Cytokin IFNg induziert die Expression und Inkorporation der alternativen katalytisch aktiven Immunountereinheiten, was in variablen Isoformen des 20S Proteasoms resultiert. Die zusätzliche Assoziation des 19S Regulators, bzw. des PA28 und des PA200 Aktivators an eine Isoform erweitert das Sortiment an proteasomalen Komplexsubtypen. Der zeitliche Verlauf einer IFNg Stimulation zeigte, dass die Aktivatoren PA28 und PA200 antagonistisch an das 20S Proteasom assoziieren und niedermolekulare Komplexsubtypen bilden, sodass in dieser Studie auch zum ersten Mal eine IFNg abhängige Assoziation des PA200 Monomers an das 20S Proteasom detektiert wurde. Ex vivo Versuche zeigten, dass die Defizienz der Immunountereinheit LMP7 mit der Assoziation des PA28-Aktivators an das 20S-19S Proteasom kompensiert wird, wobei die funktionelle Wirksamkeit aber offen bleibt. In einer monozytären Zelllinie wird ein sehr hochmolekularer, chymotryptisch aktiver Komplex assembliert und massenspektrometrische Analysen detektierten proteasomale Untereinheiten und viele Komponenten der Proteinbiosynthese, was für eine Assoziation des Proteasoms mit dem Polysom spricht. Diese Möglichkeit der kotranslationalen Degradation kann auch die Assoziation des detektieren Chaperonins TriC erklären, wobei dieser Komplex, der ATP abhängig Proteine faltet, möglicherweise auch direkt mit dem Proteasom interagieren könnte, wie elektronenmikroskopische Aufnahmen belegten. Neben den neuen strukturellen Ergebnissen, bestätigte die funktionelle Analyse den Abbau polyubiquitinierter Substrate durch 19S-Regulator assoziierte Komplexsubtypen, doch das 19S-20S-19S Proteasom konnte das Modellsubstrat HA-Ubi-IkBa-flag besser abbauen und deubiquitinieren als das 20S-19S Proteasom. / The 20S proteasome is the core element of the ubiquitin-proteasome-system, which degrades defective, unneeded and oxidized proteins, while three catalytically active subunits hydrolyze the peptide bonds of the polypeptide. The proinflammatory cytokine IFNg induces the expression and incorporation of three alternative, catalytically active immunosubunits resulting in variable isoforms of the 20S proteasome. The additional association of the 19S regulator, or the PA28 and PA200 activator, respectively, expands the range of proteasome complex subtypes. The time course of IFNg stimulation showed that the proteasomal association of PA28 and PA200 occurs antagonistically, forming low molecular weight complex subtypes. Furthermore, this study revealed for the first time an IFNg dependent association of the PA200 monomer to the 20S proteasome. Ex vivo experiments showed that the deficiency of the immunosubunit LMP7 is compensated by the association of the PA28 activator to the 20S-19S proteasome, whereas the functional efficacy remains elusive. In a monocytic cell line, a chymotryptic active complex with a very high molecular weight was detected, and mass spectrometry confirmed proteasomal subunits and components of the protein synthesis machinery, suggesting an association of the proteasome with the polysome. The fact of cotranslational degradation may also explain the association of the chaperonin TriC, an ATP dependent protein folding chaperonin. Electron micrographs could reveal that TriC possibly interacts directly with the proteasome. Next to the new structural results, the functional analysis confirmed the degradation of polyubiquitinated substrates by 19S regulator associated complex subtypes, and in addition to it, the 19S-20S-19S proteasome degraded and deubiquitinated the model substrate HA-Ubi-IkBa-flag better than the 20S-19S proteasome.